


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:03:44Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407884" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407884</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>reben</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Enferm</journal-id><journal-id journal-id-type="iso-abbrev">Rev Bras Enferm</journal-id><journal-id journal-id-type="pmc-domain-id">4332</journal-id><journal-id journal-id-type="pmc-domain">reben</journal-id><journal-id journal-id-type="publisher-id">reben</journal-id><journal-title-group><journal-title>Revista Brasileira de Enfermagem</journal-title></journal-title-group><issn pub-type="ppub">0034-7167</issn><issn pub-type="epub">1984-0446</issn><publisher><publisher-name>Associa&#231;&#227;o Brasileira de Enfermagem</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407884</article-id><article-id pub-id-type="pmcid-ver">PMC12407884.1</article-id><article-id pub-id-type="pmcaid">12407884</article-id><article-id pub-id-type="pmcaiid">12407884</article-id><article-id pub-id-type="pmid">40900539</article-id><article-id pub-id-type="doi">10.1590/0034-7167-2024-0245</article-id><article-id pub-id-type="other">00165</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Construction and validation of an educational booklet on HIV pre-exposure prophylaxis</article-title><trans-title-group xml:lang="es"><trans-title>Elaboraci&#243;n y validaci&#243;n de un folleto educativo sobre la profilaxis preexposici&#243;n al VIH</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-2028-3618</contrib-id><name name-style="western"><surname>Trigo</surname><given-names initials="MA">Marina Andreoli</given-names></name><xref rid="aff1" ref-type="aff">I</xref><role>contributed to the conception or design of the study/research</role><role>contributed to the analysis and/or interpretation of data</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8365-3477</contrib-id><name name-style="western"><surname>Rocha</surname><given-names initials="KADA">Karyanna Alves de Alencar</given-names></name><xref rid="aff1" ref-type="aff">I</xref><role>contributed to the analysis and/or interpretation of data</role><role>contributed to the final review with critical and intellectual participation in the manuscript.</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4711-4788</contrib-id><name name-style="western"><surname>Antonini</surname><given-names initials="M">Marcela</given-names></name><xref rid="aff1" ref-type="aff">I</xref><role>contributed to the conception or design of the study/research</role><role>contributed to the analysis and/or interpretation of data</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1709-2143</contrib-id><name name-style="western"><surname>Rocha</surname><given-names initials="DDM">Daniel de Mac&#234;do</given-names></name><xref rid="aff1" ref-type="aff">I</xref><role>contributed to the conception or design of the study/research</role><role>contributed to the final review with critical and intellectual participation in the manuscript.</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4428-8371</contrib-id><name name-style="western"><surname>Elias</surname><given-names initials="HC">Henrique Ciabotti</given-names></name><xref rid="aff1" ref-type="aff">I</xref><role>contributed to the conception or design of the study/research</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0681-4721</contrib-id><name name-style="western"><surname>Reis</surname><given-names initials="RK">Renata Karina</given-names></name><xref rid="aff1" ref-type="aff">I</xref></contrib></contrib-group><aff id="aff1">
<label>I</label>Universidade de S&#227;o Paulo. Ribeir&#227;o Preto, S&#227;o Paulo, Brazil</aff><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Renata Karina Reis, E-mail: <email>rkreis@eerp.usp.br</email></corresp><fn fn-type="edited-by"><p><bold>EDITOR IN CHIEF:</bold> Antonio Jos&#233; de Almeida Filho</p></fn><fn fn-type="edited-by"><p><bold>ASSOCIATE EDITOR:</bold> Marcia Cubas</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>78</volume><issue>Suppl 1</issue><issue-id pub-id-type="pmc-issue-id">484363</issue-id><elocation-id>e20240245</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 16:25:19.050"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="0034-7167-reben-78-s1-e20240245.pdf"/><abstract><title>ABSTRACT</title><sec><title>Objectives:</title><p>to develop and validate an educational booklet on HIV Pre-Exposure Prophylaxis (PrEP).</p></sec><sec><title>Methods:</title><p>quantitative validation study aimed at developing and validating an educational booklet by experts and the target audience. For validation with experts, we used the Health Education Content Validation Index developed in a virtual environment. For the target audience, we used a questionnaire with questions related to organization, writing style, appearance, and motivation.</p></sec><sec><title>Results:</title><p>thirty-two experts and 13 PrEP users participated in the study. The analysis was structured on the principles of descriptive statistics, and domains that presented a Content Validity Index equal to or greater than 0.80 were considered satisfactory. The final version of the material was made available in online and printed formats.</p></sec><sec><title>Conclusions:</title><p>the educational booklet was developed and validated by experts and the target audience, serving as an educational tool to support self-care and awareness of HIV prevention for PrEP users.</p></sec></abstract><trans-abstract xml:lang="es"><title>RESUMEN</title><sec><title>Objetivos:</title><p>elaborar y validar un folleto educativo sobre la Profilaxis Preexposici&#243;n (PrEP) al VIH<bold>. M&#233;todos:</bold> es un estudio cuantitativo de validaci&#243;n destinado a elaborar y validar un folleto educativo por expertos, con el &#205;ndice de validaci&#243;n de Contenido Educativo en salud en ambiente virtual y p&#250;blico-objetivo, mediante un cuestionario sobre organizaci&#243;n, estilo de la escritura, apariencia y motivaci&#243;n.</p></sec><sec><title>Resultados:</title><p>participaron del estudio 32 expertos y 13 usuarios de la PrEP. El an&#225;lisis se estructur&#243; seg&#250;n los principios de la estad&#237;stica descriptiva, y se consideraron satisfactorios los dominios con un &#205;ndice de Validez de Contenido (IVC) igual o superior a 0,80. La versi&#243;n final del material se puso a disposici&#243;n en l&#237;nea y en versi&#243;n impresa.</p></sec><sec><title>Conclusiones:</title><p>el folleto educativo fue desarrollado y validado por expertos y p&#250;blico-objetivo, y sirve como herramienta educativa para apoyar el autocuidado y concienciar sobre la prevenci&#243;n del VIH entre los usuarios de la PrEP.</p></sec></trans-abstract><kwd-group><title>Descriptors:</title><kwd>Educational Technology</kwd><kwd>Disease Prevention</kwd><kwd>HIV</kwd><kwd>Pre-Exposure Prophylaxis</kwd><kwd>Nursing</kwd></kwd-group><kwd-group xml:lang="es"><title>Descriptores:</title><kwd>Tecnolog&#237;a Educacional</kwd><kwd>Prevenci&#243;n de Enfermedades</kwd><kwd>VIH</kwd><kwd>Profilaxis Preexposici&#243;n</kwd><kwd>Enfermer&#237;a</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Human immunodeficiency virus (HIV) infection continues to be a global public health challenge, with 85.6 million people infected and 40.4 million AIDS-related deaths recorded since the pandemic began. In 2022, 1.3 million new cases of HIV were diagnosed, resulting in 630,000 AIDS-related deaths<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>.</p><p>In view of the great concern about controlling the transmission of the virus, during the United Nations summit on Sustainable Development Goals (SDGs) in September 2015, 17 goals were established: among them, goal number 3 is described as health and well-being, which encompasses targets related to the topic. One of its goals is the eradication of AIDS and other neglected diseases. The elimination of AIDS is an important goal for public health, since it claimed approximately 630,000 lives in 2022, according to UNAIDS statistics, demonstrating that even with the advances achieved by science and the joint efforts of nations, aiming to interrupt the chain of transmission and reduce the number of new infections, significant losses still occur<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup>.</p><p>Pre-Exposure Prophylaxis (PrEP) was implemented in Brazil in 2017 for populations exposed to HIV, with indication criteria expanded to the entire population over 15 years old and weighing more than 35 kg, including serodifferent couples and people who use injectable drugs<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>. PrEP is a daily drug therapy with oral antiretrovirals, safe, with few side effects and with proven protective efficacy of over 90% when used correctly<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>. Despite its effectiveness, knowledge about PrEP among the population is still limited or lacking, which hinders its widespread adoption<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup>. One of the main challenges currently faced by health professionals is how accessible the communication of information about Pre-Exposure Prophylaxis (PrEP) is, meeting the needs and doubts of both individuals and the community in a clear and objective manner<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>. The demand for health education is widespread, and there is constant discussion about ways to provide information and scientific updates in an accessible manner to the population, ensuring that they can understand and use content based on reliable evidence. In addition, the way in which this information is made available directly influences the learning process and, consequently, the health of individuals<sup>(<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>)</sup>.</p><p>Educational technology is a crucial tool in nursing to promote health prevention strategies, including HIV awareness and prevention methods, such as combination prevention. It is also important for individuals with HIV to maintain their viral load undetectable through treatment, thus interrupting the transmission cycle<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>Considering the difficulty of the population&#8217;s access to clear and objective information about PrEP, as well as the need to strengthen AIDS prevention strategies, as outlined in the third objective of the Sustainable Development Goals (SDGs), it is imperative to create easily accessible and understandable material to promote health education. Thus, this study aimed to create and validate an educational booklet on HIV Pre-Exposure Prophylaxis (PrEP).</p></sec><sec><title>OBJECTIVES</title><p>To develop and validate an educational booklet on HIV Pre-Exposure Prophylaxis (PrEP).</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Ethical aspects</title><p>The study was approved by the Research Ethics Committee, ensuring compliance with the recommendations of Resolution Number 466/12. It was conducted using the Research Electronic Data Capture Platform (REDCAp)<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> with national coverage.</p></sec><sec><title>Study design, period and setting</title><p>This is a quantitative validation study, developed in three stages: construction of the educational booklet, content validation with experts and validation with the target audience, carried out from December 2022 to February 2024. This study follows the guidelines of the Revised Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0)<sup>(<xref rid="B11" ref-type="bibr">11</xref>-<xref rid="B14" ref-type="bibr">14</xref>)</sup>.</p></sec><sec><title>Construction of the educational booklet</title><p>The pre-production stage of the educational booklet consisted of a literature review on HIV Pre-Exposure Prophylaxis, articulated with the recommendations of the Clinical Protocol and Therapeutic Guidelines for Pre-Exposure Prophylaxis (PrEP) (2022) for HIV infection risk and current international scientific evidence, from May to December 2022<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>. The publications underwent critical reading in order to extract useful information to be included in the educational booklet, defining the main topics and their objectives.</p><p>The production of the educational booklet included layout and infographics to facilitate understanding. A designer specialized in health educational materials was hired for this purpose. The process took place from December 2022 to July 2023, following the guidelines proposed by Moreira (2003) to create effective educational material in terms of language, layout and illustrations.</p></sec><sec><title>Sample and eligibility criteria for validation</title><p>To identify and select the experts, a criteria that demonstrate expertise in specific health knowledge on the study topic was necessary, according to criteria adopted by Fehring (1994)<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>. In order to validate the educational booklet, we invited PrEP patients undergoing follow-up at the Central Specialty Reference Center of Ribeir&#227;o Preto city, between October and December 2023. The inclusion criteria were: being over 18 years old, clinical stability, lucidity and willingness to read the booklet. Data collection was performed in a room in the service to ensure confidentiality. Patients with visual or cognitive impairment were excluded. Participants were selected consecutively during the study period. Free and Informed Consent was obtained from all individuals involved in the study online.</p></sec><sec><title>Expert validation</title><p>The validation stage was carried out virtually, reflecting trends in using digital means to facilitate empirical studies, serving as a means for collecting and disseminating results<sup>(<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>)</sup>. Recruitment used the Snowball method, as described by Fernandes and Carvalho (2003)<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>, adapted for use in virtual social networks as a means of collecting data and disseminating scientific results.</p><p>The evaluation of the educational booklet was conducted through a self-administered and virtual questionnaire, inserted in the REDCap platform<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> and adapted from the Nursing Diagnosis Content Validation model proposed by Fehring (1994)<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>. The questionnaire used a Likert-type scale to analyze the booklet in different aspects, from its objectives to its structure, presentation and relevance. Participants were able to provide suggestions and observations on the evaluated attributes, including identifying errors or requesting the addition of relevant content.</p></sec><sec><title>Target audience validation</title><p>During PrEP follow-up consultations at the specialized service, one of the researchers from the AIDS and STD Center (NAIDST) approached users and invited them to participate in the validation. After acceptance, participants received a semi-structured questionnaire on sociodemographic data, a validation questionnaire prepared by the researchers, and the educational booklet in virtual format. The validation questionnaire, adapted from a previous study, contained 20 questions grouped into organization, writing, appearance, and motivation. Responses were categorized as totally agree/agree (positive responses) and disagree/totally disagree (negative responses).</p></sec><sec><title>Analysis of results and statistics</title><p>To analyze the experts&#8217; responses, the Content Validation Index (CVI)<sup>(<xref rid="B17" ref-type="bibr">17</xref>)</sup> was used, which measures the proportion of agreement among evaluators. Consensus was considered satisfactory when the CVI was equal to or greater than 80%. The CVI allowed verifying the experts&#8217; agreement regarding the representativeness of the content. To evaluate the users&#8217; responses, the Agreement Index (AI)<sup>(<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B21" ref-type="bibr">21</xref>)</sup> was used, which calculates the number of agreements divided by the total number of evaluations. An agreement greater than or equal to 0.8 was considered satisfactory. Sociodemographic data were analyzed descriptively, presented in tables, and contributed to possible modifications to the booklet, resulting in its final version. The study was approved by the Research Ethics Committee of the Ribeir&#227;o Preto School of Nursing, University of S&#227;o Paulo.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Construction of the educational booklet</title><p>The educational booklet entitled Pre-Exposure Prophylaxis for the Human Immunodeficiency Virus: another option for preventing HIV (2024) has 16 pages, divided into five topics with illustrations and short informative texts. To create the educational booklet, basic information about PrEP<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup> was gathered from the Clinical Protocol and Therapeutic Guidelines for Pre-Exposure Prophylaxis (PrEP) for Risk of HIV Infection (2022), and a professional designer was hired, considering the distribution of elements in a cohesive way, using colors associated with the health theme and aesthetically pleasing, as seen in <xref rid="f1" ref-type="fig">Figure 1</xref>.</p><p>
<fig position="float" id="f1" orientation="portrait"><label>Figure 1</label><caption><title>Educational booklet: Pre-Exposure Prophylaxis to the Human Immunodeficiency Virus</title></caption><graphic position="float" orientation="portrait" xlink:href="0034-7167-reben-78-s1-e20240245-gf01.jpg"/><attrib><italic toggle="yes">Source: Educational booklet on PrEP, 2024.</italic></attrib></fig>
</p><p>The first topic of the educational booklet, entitled &#8220;Pre-Exposure Prophylaxis for HIV, how does it work?&#8221;, describes how the medications work and the indication for PrEP. The second topic, &#8220;Efficacy and Benefit&#8221;, addresses issues such as when PrEP starts to take effect, the necessary monitoring, benefits and side effects. The third topic, &#8220;I want to use it&#8221;, answers who can use PrEP, how to start and continue its use, based on the Brazilian protocol. The content was adapted to be accessible, free of complex technical terms and playful, aiming to reach and be understood by the population in different contexts. The fourth topic, &#8220;Strategies for not forgetting to take it&#8221;, offers six simple guidelines to improve adherence to PrEP, such as note-taking and the use of alarm clocks. Finally, the fifth topic, &#8220;Where to find more information&#8221;, lists official websites and electronic addresses for additional information about PrEP<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>Infographics were inserted throughout the text to facilitate reading, and elements were created to reinforce the written message. The predominant color used was blue, which Fernandes and Ara&#250;jo (2018)<sup>(<xref rid="B23" ref-type="bibr">23</xref>)</sup> describe as a color capable of bringing a sense of calm and relaxation and dispelling the feeling of rushing and agitation that individuals carry every day.</p></sec><sec><title>Validation of the educational booklet by experts</title><p>The educational booklet validation stage involved the participation of 32 experts. These were predominantly nursing graduates, 29 (93.5%), and female, 18 (56.3%) from different regions of the country. The average length of experience in the field was 8.4 years (SD=9.0). Regarding the field of activity, 11 (34.4%) of the experts worked in healthcare; 10 (31.3%) in teaching, and 9 (28.1%) in research. Out of the 32 participants, 15 (46.9%) worked in the field of infectious diseases, 8 (26.7%) had a doctorate as their highest level of education; 16 (53.3%) had knowledge of HIV/AIDS acquired at work; and 6 (20.0%) through publications in the field. Among the participants, 28 (87.5%) worked and provided daily guidance to users on PrEP. The educational booklet validation questionnaire comprises 55 attributes, each with statements evaluated by experts, ranging from &#8220;Totally agree&#8221; to &#8220;Totally disagree&#8221;. Validation of an attribute requires that the sum of the responses &#8220;Totally agree&#8221; and &#8220;Agree&#8221; be greater than 80% of the total responses. The attributes are distributed into three domains: &#8220;Overall evaluation&#8221;, &#8220;Content&#8221; and &#8220;Aesthetic and visual quality&#8221;. The &#8220;Overall evaluation&#8221; domain includes 10 attributes, listed in <xref rid="t1" ref-type="table">Table 1</xref>, along with their respective I-CVIs.</p><table-wrap position="float" id="t1" orientation="portrait"><label>Table 1</label><caption><title>Overall evaluation of the educational booklet by health experts (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brazil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Attributes evaluated</th><th align="center" rowspan="2" colspan="1">SA</th><th align="center" rowspan="2" colspan="1">A</th><th align="center" rowspan="2" colspan="1">DK</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">SD</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" rowspan="1" colspan="1">General assessment</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding for PrEP usage.</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding of the effectiveness of PrEP.</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding PrEP&#8217;s benefits.</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding of the possible side effects of PrEP.</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding of the eligibility criteria for PrEP use.</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in a way that allows understanding of adherence to PrEP.</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in such a way as to allow the understanding of facilitating strategies for monitoring PrEP.</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet is described in such a way as to allow the understanding of facilitating strategies for monitoring PrEP.</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" rowspan="1" colspan="1">It is consistent with the needs of people using PrEP</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">It is consistent with the needs of people using PrEP</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.97</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>
<italic toggle="yes">Number of experts who chose the option: SA - Strongly agree; A - Agree; DK - Don&#8217;t know; D - Disagree; SD - Strongly disagree. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>The content and written language domain (<xref rid="t2" ref-type="table">Table 2</xref>), composed of 22 attributes, achieved an S-CVI/Ave of 0.96, ranging from 0.88 to 1.00. After analyzing the experts&#8217; suggestions, it was identified the need to reinforce the possible contraindications to the concomitant use of PrEP, emphasize that it does not prevent other STIs and improve the exposure on the use of internal and external condoms.</p><table-wrap position="float" id="t2" orientation="portrait"><label>Table 2</label><caption><title>Evaluation of content and written language of the educational booklet by health experts (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brazil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Attributes evaluated</th><th align="center" rowspan="2" colspan="1">SA</th><th align="center" rowspan="2" colspan="1">A</th><th align="center" rowspan="2" colspan="1">DK</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">SD</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Content</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on the use of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on the effectiveness of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on the benefits of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on the possible side effects of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on the eligibility criteria for PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on adherence to PrEP treatment.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for guidance on strategies to facilitate PrEP monitoring.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The sequence of the booklet's content is appropriate.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows for understanding the topic.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content covered is in accordance with current knowledge.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows for understanding the use of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows for understanding the effectiveness of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows for understanding the benefits of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows for understanding the possible side effects of PrEP.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content is appropriate for the target audience (adults using PrEP) PrEP).</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows the understanding of adherence to PrEP treatment.</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The content allows the understanding of strategies that facilitate PrEP monitoring.</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The guidelines presented are relevant.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The guidelines presented were addressed correctly.</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The information is appropriate for the target audience.</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The information is presented in a context that is relevant to the target audience</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet contains all the information necessary for using PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.96</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p>
<italic toggle="yes">Number of experts who chose the option: SA - Strongly agree; A - Agree; DK - Don&#8217;t know; D - Disagree; SD - Strongly disagree. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>The last domain assessed by the experts was the aesthetic and visual quality of the educational booklet, consisting of 8 attributes. The objective was to verify whether the material is attractive and arouses interest through its colors and images. The domain obtained a total CVI of 0.91, meeting the minimum value required for approval in all attributes, as shown in <xref rid="t3" ref-type="table">Table 3</xref>. However, the experts suggested improvements, such as increasing the font size, including more diverse characters and making the booklet more colorful and attractive, especially for teenagers.</p><table-wrap position="float" id="t3" orientation="portrait"><label>Table 3</label><caption><title>Evaluation of the aesthetic and visual quality of the educational booklet by health experts (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brazil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Attributes evaluated</th><th align="center" rowspan="2" colspan="1">SA</th><th align="center" rowspan="2" colspan="1">A</th><th align="center" rowspan="2" colspan="1">DK</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">SD</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Aesthetic and visual quality</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">The visual aspect of the booklet is interesting.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The visual aspect of the booklet motivates its reading.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The booklet has a satisfactory aesthetic/layout.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The format and size of the letters are satisfactory.</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The infographics created retain the written guidelines.</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The quality of the infographics is satisfactory.</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The colors used do not hinder reading.</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The layout favors understanding of the message.</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.91</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>*</label><p>
<italic toggle="yes">N&#186; de especialistas que escolheram a op&#231;&#227;o: CT - Concordo totalmente; C - Concordo; NS - N&#227;o sei; D - Discordo; DT - Discordo totalmente. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>The experts&#8217; suggestions were accepted and a final version of the educational booklet was prepared taking into account the modifications suggested by experts as relevant to composing the educational booklet.</p><p>The overall Content Validity Index (S-CVI/UA) of the validation with the experts was given by the average of the total IVC, that is, the sum of the S-CVI/Ave of each domain divided by the number of domains (4), whose result was 0.94, thus validating the educational booklet through all the Content Validity Index (by attributes, domain and overall) reaching a value equal to or greater than 0.80.</p></sec><sec><title>Validation of the educational booklet by the target audience</title><p>The validation with the target audience included 13 PrEP users, with an average age of 36.7 years, all male, cisgender and men who have sex with men (MSM). The majority of participants (84.6%) were single, and the majority had completed college (38.5%) and were employed (46.2%). All participants (100%) were current PrEP users, received follow-up guidance and intended to continue using it. The results regarding the organization of the material, writing style, appearance and motivation are presented in <xref rid="t4" ref-type="table">Table 4</xref>.</p><table-wrap position="float" id="t4" orientation="portrait"><label>Table 4</label><caption><title>Evaluation of the organization, writing style, appearance and motivation of the educational booklet by the target audience (n=13), Ribeir&#227;o Preto, S&#227;o Paulo, Brazil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Attributes evaluated</th><th align="center" rowspan="2" colspan="1">CT/C</th><th align="center" rowspan="2" colspan="1">D/DT</th><th align="center" rowspan="2" colspan="1">IVC</th></tr><tr><th align="left" rowspan="1" colspan="1">Organization</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">The information provided in the booklet is easy to understand.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The information provided in the booklet is important.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The information in the booklet helps me decide whether or not I want to use PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">Writing and appearance</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">I liked how the content of the booklet was presented.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The images help to understand the content of the booklet.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The colors used in the booklet are attractive.</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet makes it possible to understand what PrEP is.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet makes it possible to understand the benefits of using PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet helped me understand the importance of professional monitoring while using PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet makes it possible to understand the possible side effects of PrEP.</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet helps to understand some precautions that should be taken while using PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet allows me to know where to get PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet makes it possible to understand who can use PrEP.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Motivation</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">The booklet can be a facilitator in the search for PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The booklet made me realize that I meet the criteria for indication for PrEP.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">The information in this booklet made me interested in seeking/starting PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">The information in this booklet can help improve adherence to PrEP.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">I know someone who would benefit from reading this booklet.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">This booklet can be a complementary tool in sexual education activities for people over 16 years old.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>*</label><p>
<italic toggle="yes">Number of experts who chose the option: SA - Strongly agree; A - Agree; DK - Don&#8217;t know; D - Disagree; SD - Strongly disagree. I-CVI=Item-Level Content Validity Index, 2024.</italic>
</p></fn></table-wrap-foot></table-wrap><p>Two negative responses were highlighted in the target audience evaluations, resulting in a CI of 0.85 in the written category. Participants were invited to provide suggestions and comments, which addressed the need for details on where to seek PrEP in the SUS and in the private system. Positive observations were also recorded, praising the easy understanding and relevance of the booklet for those who want or use PrEP.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This study describes the development and validation of an educational booklet for HIV Pre-Exposure Prophylaxis (PrEP) users, with the aim of supporting their prevention and self-care strategies. Developed based on the literature and validated by health professionals and PrEP users, this educational tool aims to promote the conscious use of PrEP and expand its reach. The use of educational technologies such as this booklet is essential to increase knowledge, promote autonomy and facilitate self-care, especially in a context where verbal guidance predominates, ensuring that the educational needs of PrEP users are met in an individualized and person-centered manner.</p><p>In the current context, the fight against AIDS has continued for more than four decades, and it is still considered a disease full of social stigmas, especially related to sexual minorities, such as LGBTQIA+<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup>. Over this time, there have been great advances in the areas of health and technology, facilitating access to new information. In fact, greater access to information by the population directly impacts public health issues, since health literacy provides individuals with the ability to exercise autonomy over their health processes and strengthen decision-making in a more conscious and informed manner<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>Controlling HIV transmission is still a major global challenge, and as such, several goals have been established in an attempt to achieve it. An example of this is one of the SDG goals, specifically the goal of health and well-being, which aims to eliminate AIDS by 2030<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup>. Thus, one way to help achieve the eradication of AIDS is through health literacy among the population regarding prevention methods. For this process to occur, teaching materials that facilitate the understanding of information are necessary<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup>.</p><p>Educational technologies have played a fundamental role in health education, especially by directing strategies to raise awareness of issues that deal with certain topics; through playful and interactive exposure to the target audience; It can be written with easy understanding in mind, using simplified language and including relevant information<sup>(<xref rid="B24" ref-type="bibr">24</xref>)</sup>. In the case of the booklet developed during this study, it serves the purpose of raising awareness among the target audience about the struggles to eradicate AIDS, prevention and greater safety, with the guarantee of reliable, up-to-date evidence written in an accessible manner, both in terms of vocabulary and easy interpretation.</p><p>An educational booklet, whether in printed or online format, helps to disseminate knowledge with a broad reach to individuals in both modalities. The educational booklet that aims at health literacy, containing easy-to-understand texts and self-explanatory images that facilitate the understanding of the material, especially, has the potential to reach vulnerable populations, since they do not need adjacent support, such as an internet connection and electronic devices for reading. Thus, it is a great tool for health professionals, in the context of confronting and implementing health prevention strategies<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>The educational booklet addressed the main topics identified in the scientific evidence related to PrEP, such as its functioning, indication, efficacy, benefits and side effects, obtaining a Global Content Validity Index (S-CVI/UA) of 0.94, above the target considered for approval, which is an index higher than 0.80. Thus, it is considered valid by health experts and the target audience for future use as an educational technology with the population, since the booklet was developed in order to provide updated information on PrEP in an accessible way.</p><p>Validation with the target audience revealed a generally positive assessment of the booklet in relation to its writing, appearance and motivation. Despite some opinions about the colors, most users considered it useful for promoting health education beyond the specialized service. The colors were adjusted to better suit the users&#8217; profile, and the writing of side effects was simplified. This validation is crucial to identify gaps in understanding and ensure that the educational material is accessible and relevant to different levels of health literacy. An organized and attractive presentation of the content is essential for effective reading, aligned with the interests and needs of readers.</p><p>A well-developed educational booklet is a valuable resource in health education strategies, facilitating understanding, being accessible and reinforcing the guidelines provided verbally by the health team. The printed format offers the advantage of being able to be consulted later, serving as support for consultations and readings over time and favoring communication with the health team. It is also worth noting that the booklet does not replace the health professional in health education actions; however, it can facilitate communication and encourage self-care<sup>(<xref rid="B24" ref-type="bibr">24</xref>)</sup>.</p><sec><title>Study limitations</title><p>The booklet was validated with young adults with a high level of education who were already linked to a specialized service, excluding groups with low levels of education. Despite this, all stages were completed. The validated population reflects real PrEP users in the country. It is suggested that other educational technologies, such as games and videos, can be created to reach different population groups.</p></sec><sec><title>Contributions to the area</title><p>The development and validation of a new booklet for PrEP users represents an important educational technology that is low cost and easy to implement in health services. It can reach a wide audience and be used in educational interventions as a teaching-learning strategy by nursing staff and other health professionals. This study addresses the main topics to be included in the guidelines for the use of PrEP, highlighting the importance of nurses in the health education process.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>The educational booklet on PrEP was prepared in five topics and validated by experienced professionals and users. Its final printed version can be used as a complementary resource to the guidance provided by nurses and doctors during specialized monitoring, thus helping to ensure universal access to quality health services. Such access is crucial to achieving the third of the UN Sustainable Development Goals. In addition, the booklet aims to strengthen health literacy about PrEP, a free HIV prevention method provided by the SUS. This empowers individuals to make informed decisions about their health, thus promoting their empowerment and autonomy.</p></sec></body><back><sec sec-type="data-availability" specific-use="uninformed"><label>AVAILABILITY OF DATA AND MATERIAL</label><p>Not applicable.</p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>UNAIDS</collab></person-group><source>Estat&#237;sticas globais sobre HIV e AIDS: ficha informativa de 2022</source><comment>[Internet]</comment><publisher-loc>Genebra</publisher-loc><publisher-name>ONUSIDA;</publisher-name><year>2022</year><date-in-citation content-type="access-date">cited 2022 Mar 7</date-in-citation><comment>Available from: <ext-link xlink:href="https://www.unAIDS.org/en/resources/fact-sheet" ext-link-type="uri">https://www.unAIDS.org/en/resources/fact-sheet</ext-link></comment></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>ODS BRASIL</collab></person-group><source>Indicadores Brasileiros para os Objetivos de Desenvolvimento Sustent&#225;vel</source><comment>[Internet]</comment><publisher-loc>Bras&#237;lia</publisher-loc><year>2022</year><date-in-citation content-type="access-date">cited 2023 Dec 9</date-in-citation><comment>Available from: <ext-link xlink:href="https://odsbrasil.gov.br" ext-link-type="uri">https://odsbrasil.gov.br</ext-link></comment></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonini</surname><given-names>M</given-names></name><name name-style="western"><surname>Silva</surname><given-names>IE</given-names></name><name name-style="western"><surname>Elias</surname><given-names>HC</given-names></name><name name-style="western"><surname>Gerin</surname><given-names>L</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>AC</given-names></name><name name-style="western"><surname>Reis</surname><given-names>RK.</given-names></name></person-group><article-title>Barreiras para o uso da Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) ao HIV: uma revis&#227;o integrativa</article-title><source>Rev Bras Enferm</source><year>2023</year><volume>76</volume><fpage>e20210963</fpage><pub-id pub-id-type="doi">10.1590/0034-7167-2021-0963pt</pub-id><pub-id pub-id-type="pmid">37377313</pub-id><pub-id pub-id-type="pmcid">PMC10292616</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Minist&#233;rio da Sa&#250;de (BR)</collab></person-group><source>Protocolo Cl&#237;nico e Diretrizes Terap&#234;uticas para Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) de Risco &#224; Infec&#231;&#227;o pelo HIV</source><comment>[Internet]</comment><year>2022</year><date-in-citation content-type="access-date">cited 2023 Dec 9</date-in-citation><comment>Available from: <ext-link xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_clinico_profilaxia_prep.pdf" ext-link-type="uri">https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_clinico_profilaxia_prep.pdf</ext-link></comment></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silveira</surname><given-names>PPS</given-names></name><name name-style="western"><surname>Silva</surname><given-names>BS</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>CV</given-names></name><name name-style="western"><surname>Lima</surname><given-names>ES</given-names></name><name name-style="western"><surname>Santos</surname><given-names>KA</given-names></name><name name-style="western"><surname>Banhato</surname><given-names>L</given-names></name><etal/></person-group><article-title>Uso da Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) como preven&#231;&#227;o combinada na conten&#231;&#227;o da dissemina&#231;&#227;o do V&#237;rus da Imunodefici&#234;ncia Humana (HIV) em grupos de risco</article-title><source>Rev Eletr Acervo Sa&#250;de</source><year>2022</year><volume>15</volume><issue>6</issue><fpage>e10267</fpage><pub-id pub-id-type="doi">10.25248/reas.e10267.2022</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zucchi</surname><given-names>EM</given-names></name><name name-style="western"><surname>Grangeiro</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferraz</surname><given-names>D</given-names></name><name name-style="western"><surname>Pinheiro</surname><given-names>TF</given-names></name><name name-style="western"><surname>Alencar</surname><given-names>T</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>L</given-names></name><etal/></person-group><article-title>Da evid&#234;ncia &#224; a&#231;&#227;o: desafios do Sistema &#218;nico de Sa&#250;de para ofertar a profilaxia pr&#233;-exposi&#231;&#227;o sexual (PrEP) ao HIV &#224;s pessoas em maior vulnerabilidade</article-title><source>Cad Sa&#250;de P&#250;blica</source><year>2018</year><fpage>34</fpage><pub-id pub-id-type="doi">10.1590/0102-311X00206617</pub-id><pub-id pub-id-type="pmid">30043853</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maia</surname><given-names>NMFES</given-names></name><name name-style="western"><surname>Silva</surname><given-names>FAA</given-names></name><name name-style="western"><surname>Santos</surname><given-names>AMRD</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>EMLR</given-names></name><name name-style="western"><surname>Santos</surname><given-names>FBO</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>AAC.</given-names></name></person-group><article-title>Tecnologias educacionais para o ensino de hist&#243;ria da enfermagem: revis&#227;o integrativa</article-title><source>Acta Paul Enferm</source><year>2022</year><volume>35</volume><fpage>eAPE03017</fpage><pub-id pub-id-type="doi">10.37689/acta-ape/2022AR0003017</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heck</surname><given-names>LO</given-names></name><name name-style="western"><surname>Carrara</surname><given-names>BS</given-names></name><name name-style="western"><surname>Ventura</surname><given-names>CA.</given-names></name></person-group><article-title>Enfermagem e a Advocacia em Sa&#250;de: Processo de Elabora&#231;&#227;o de Cartilha Educativa</article-title><source>Texto Contexto Enferm</source><year>2022</year><fpage>31</fpage><pub-id pub-id-type="doi">10.1590/1980-265X-TCE-2021-0364pt</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patridge</surname><given-names>EF</given-names></name><name name-style="western"><surname>Bardyn</surname><given-names>TP.</given-names></name></person-group><article-title>Captura eletr&#244;nica de dados de pesquisa (REDCap)</article-title><source>J Assoc Bibliot Med</source><year>2018</year><volume>106</volume><issue>1</issue><fpage>142</fpage><pub-id pub-id-type="doi">10.5195/jmla.2018.319</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodman</surname><given-names>D</given-names></name><name name-style="western"><surname>Ogrinc</surname><given-names>G</given-names></name><name name-style="western"><surname>Davies</surname><given-names>L</given-names></name><name name-style="western"><surname>Baker</surname><given-names>GR</given-names></name><name name-style="western"><surname>Barnsteiner</surname><given-names>J</given-names></name><name name-style="western"><surname>Foster</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Explica&#231;&#227;o e elabora&#231;&#227;o das Diretrizes SQUIRE (Standards for Quality Improvement Reporting Excellence), V. 2.0: exemplos de elementos SQUIRE na literatura sobre melhoria da sa&#250;de</article-title><source>Qual Saf Health Care</source><year>2016</year><volume>25</volume><issue>12</issue><fpage>e7</fpage><lpage>e7</lpage><pub-id pub-id-type="doi">10.1136/bmjqs-2015-004480</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreira</surname><given-names>MF</given-names></name><name name-style="western"><surname>N&#243;brega</surname><given-names>MM</given-names></name><name name-style="western"><surname>Silva</surname><given-names>MI.</given-names></name></person-group><article-title>Comunica&#231;&#227;o escrita: contribui&#231;&#227;o para a elabora&#231;&#227;o de material educativo em sa&#250;de</article-title><source>Rev Bras Enferm</source><year>2003</year><volume>56</volume><issue>2</issue><fpage>184</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1590/S0034-71672003000200015</pub-id><pub-id pub-id-type="pmid">14692286</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fehring</surname><given-names>RJ.</given-names></name></person-group><article-title>The Fehringmodel</article-title><person-group person-group-type="editor"><name name-style="western"><surname>Carrol-Jonhnson</surname><given-names>RM</given-names></name><name name-style="western"><surname>Paquete</surname><given-names>M</given-names></name></person-group><source>Classification of nursing diagnoses: Proceedings of the Tenth Conference J. B. Limppincott</source><year>1994</year></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lobiondo-Wood</surname><given-names>G</given-names></name><name name-style="western"><surname>Haber</surname><given-names>J.</given-names></name></person-group><source>Pesquisa em Enfermagem</source><edition>4th</edition><publisher-loc>Rio de Janeiro</publisher-loc><publisher-name>Guanabara Koogan;</publisher-name><year>2001</year></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polit</surname><given-names>D</given-names></name><name name-style="western"><surname>Beck</surname><given-names>CT.</given-names></name></person-group><article-title>The Content Validity Index: are you sure you know what&#8217;s being reported? critique and recommendations</article-title><source>Res Nurs Health</source><year>2006</year><volume>29</volume><issue>5</issue><pub-id pub-id-type="doi">10.1002/nur.20147</pub-id><pub-id pub-id-type="pmid">16977646</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>L</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>T.</given-names></name></person-group><source>Consumos Problem&#225;ticos de Drogas em Popula&#231;&#245;es Ocultas</source><publisher-loc>Lisboa</publisher-loc><publisher-name>Instituto da Droga e da Toxicodepend&#234;ncia;</publisher-name><year>2003</year></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>BR.</given-names></name></person-group><article-title>Bola de Neve Virtual: o uso das redes sociais virtuais no processo de coleta de dados de uma pesquisa cient&#237;fica</article-title><source>Rev Interdiscipl Gest Soc</source><comment>[Internet]</comment><year>2018</year><date-in-citation content-type="access-date">cited 2024 Jan 5</date-in-citation><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>23</lpage><comment>Available from: <ext-link xlink:href="https://periodicos.ufba.br/index.php/rigs/article/view/24649/16131" ext-link-type="uri">https://periodicos.ufba.br/index.php/rigs/article/view/24649/16131</ext-link></comment></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Pasquali</surname><given-names>L.</given-names></name></person-group><source>Psicometria: teoria dos testes na psicologia e educa&#231;&#227;o</source><edition>5th</edition><publisher-loc>Rio de Janeiro</publisher-loc><publisher-name>Vozes;</publisher-name><year>2016</year></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexandre</surname><given-names>NM</given-names></name><name name-style="western"><surname>Coluci</surname><given-names>MZ.</given-names></name></person-group><article-title>Content validity in the development and adaptation processes of measurement instruments</article-title><source>Cien Saude Colet</source><year>2011</year><volume>16</volume><issue>7</issue><pub-id pub-id-type="doi">10.1590/S1413-81232011000800006</pub-id><pub-id pub-id-type="pmid">21808894</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sena</surname><given-names>JF</given-names></name><name name-style="western"><surname>Silva</surname><given-names>IP</given-names></name><name name-style="western"><surname>Lucena</surname><given-names>SK</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>AC</given-names></name><name name-style="western"><surname>Costa</surname><given-names>IK.</given-names></name></person-group><article-title>Validation of educational material for the care of people with intestinal stoma</article-title><source>Rev Latino-Am Enfermagem</source><year>2020</year><volume>28</volume><fpage>3269</fpage><pub-id pub-id-type="doi">10.1590/1518-8345.3179.3269</pub-id><pub-id pub-id-type="pmcid">PMC7217624</pub-id><pub-id pub-id-type="pmid">32401899</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>KM.</given-names></name></person-group><article-title>Qualidade percebida no uso das cores em uma cl&#237;nica de psicologia voltada para adultos</article-title><source>Plural Design</source><year>2018</year><volume>1</volume><issue>1</issue><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.21726/pl.v1i1.74</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peres</surname><given-names>F.</given-names></name></person-group><article-title>Alfabetiza&#231;&#227;o, letramento ou literacia em sa&#250;de? traduzindo e aplicando o conceito de health literacy no Brasil</article-title><source>Cien Saude Colet</source><year>2023</year><volume>28</volume><fpage>1563</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1590/1413-81232023285.14562022</pub-id><pub-id pub-id-type="pmid">37194887</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Minist&#233;rio da Sa&#250;de (BR)</collab></person-group><article-title>Departamento de Doen&#231;as de Condi&#231;&#245;es Cr&#244;nicas e Infec&#231;&#245;es Sexualmente Transmiss&#237;veis</article-title><source>PrEP (Profilaxia Pr&#233;-Exposi&#231;&#227;o)</source><comment>[Internet]</comment><publisher-name>Minist&#233;rio da Sa&#250;de</publisher-name><date-in-citation content-type="access-date">cited 2024 Apr 30</date-in-citation><comment>Available from: <ext-link xlink:href="https://www.gov.br/aids/pt-br/assuntos/prevencao-combinada/prep-profilaxia-pre-exposicao/prep-profilaxia-pre-exposicao" ext-link-type="uri">https://www.gov.br/aids/pt-br/assuntos/prevencao-combinada/prep-profilaxia-pre-exposicao/prep-profilaxia-pre-exposicao</ext-link></comment></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Programa Conjunto Das Na&#231;&#245;es Unidas Sobre HIV/AIDS</collab></person-group><source>Novo relat&#243;rio do UNAIDS mostra que podemos acabar com a AIDS at&#233; 2030</source><comment>[Internet]</comment><publisher-name>UNAIDS Brasil</publisher-name><year>2021</year><date-in-citation content-type="access-date">cited 2024 Apr 10</date-in-citation><comment>Available from: <ext-link xlink:href="https://unaids.org.br/2021/06/novo-relatorio-do-unaids-mostra-que-podemos-acabar-com-a-aids-ate-2030" ext-link-type="uri">https://unaids.org.br/2021/06/novo-relatorio-do-unaids-mostra-que-podemos-acabar-com-a-aids-ate-2030</ext-link></comment></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barcellos</surname><given-names>SR</given-names></name><name name-style="western"><surname>Joras</surname><given-names>ADR</given-names></name><name name-style="western"><surname>Constanzi</surname><given-names>AP</given-names></name><name name-style="western"><surname>Souza</surname><given-names>END.</given-names></name></person-group><article-title>Constru&#231;&#227;o e valida&#231;&#227;o de cartilha educativa para pacientes no p&#243;s-operat&#243;rio de cirurgia card&#237;aca: estudo metodol&#243;gico</article-title><source>Rev Bras Enferm</source><year>2023</year><volume>76</volume><fpage>e20220621</fpage><pub-id pub-id-type="doi">10.1590/0034-7167-2022-0621pt</pub-id><pub-id pub-id-type="pmid">38055473</pub-id><pub-id pub-id-type="pmcid">PMC10695027</pub-id></element-citation></ref></ref-list></back><sub-article article-type="translation" id="s1" xml:lang="pt"><front-stub><article-id pub-id-type="doi">10.1590/0034-7167-2024-0245pt</article-id><article-categories><subj-group subj-group-type="heading"><subject>Artigo Original</subject></subj-group></article-categories><title-group><article-title>Constru&#231;&#227;o e valida&#231;&#227;o de cartilha educativa sobre a profilaxia pr&#233;-exposi&#231;&#227;o ao HIV</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-2028-3618</contrib-id><name name-style="western"><surname>Trigo</surname><given-names initials="MA">Marina Andreoli</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff2" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8365-3477</contrib-id><name name-style="western"><surname>Rocha</surname><given-names initials="KADA">Karyanna Alves de Alencar</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><role>revis&#227;o final com participa&#231;&#227;o cr&#237;tica</role><role>intelectual no manuscrito</role><xref rid="aff2" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4711-4788</contrib-id><name name-style="western"><surname>Antonini</surname><given-names initials="M">Marcela</given-names></name><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><xref rid="aff2" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1709-2143</contrib-id><name name-style="western"><surname>Rocha</surname><given-names initials="DDM">Daniel de Mac&#234;do</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>revis&#227;o final com participa&#231;&#227;o cr&#237;tica</role><role>intelectual no manuscrito</role><xref rid="aff2" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4428-8371</contrib-id><name name-style="western"><surname>Elias</surname><given-names initials="HC">Henrique Ciabotti</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><xref rid="aff2" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0681-4721</contrib-id><name name-style="western"><surname>Reis</surname><given-names initials="RK">Renata Karina</given-names></name><role>revis&#227;o final com participa&#231;&#227;o cr&#237;tica</role><role>intelectual no manuscrito</role><xref rid="aff2" ref-type="aff">I</xref></contrib></contrib-group><aff id="aff2">
<label>I</label>Universidade de S&#227;o Paulo. Ribeir&#227;o Preto, S&#227;o Paulo, Brasil</aff><author-notes><corresp id="c2"><bold>Autor Correspondente:</bold> Renata Karina Reis, E-mail: <email>rkreis@eerp.usp.br</email></corresp><fn fn-type="edited-by"><p>EDITOR CHEFE: Antonio Jos&#233; de Almeida Filho</p></fn><fn fn-type="edited-by"><p>EDITOR ASSOCIADO: Marcia Cubas</p></fn></author-notes><abstract><title>RESUMO</title><sec><title>Objetivos:</title><p>construir e validar uma cartilha educativa sobre a Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) ao HIV.</p></sec><sec><title>M&#233;todos:</title><p>estudo de valida&#231;&#227;o, quantitativo, voltado para a constru&#231;&#227;o e valida&#231;&#227;o de cartilha educativa, por especialistas e p&#250;blico-alvo. Para a valida&#231;&#227;o com especialistas, utilizou-se o &#205;ndice de Valida&#231;&#227;o de Conte&#250;do Educativo em sa&#250;de desenvolvido em ambiente virtual, e com o p&#250;blico-alvo utilizou-se um question&#225;rio com quest&#245;es relacionadas &#224; organiza&#231;&#227;o, estilo da escrita, apar&#234;ncia e motiva&#231;&#227;o.</p></sec><sec><title>Resultados:</title><p>participaram do estudo 32 especialistas e 13 usu&#225;rios de PrEP. A an&#225;lise foi estruturada nos princ&#237;pios da estat&#237;stica descritiva, considerados satisfat&#243;rios os dom&#237;nios que apresentaram &#205;ndice de Validade de Conte&#250;do igual ou superior &#224; 0,80. A vers&#227;o final do material foi disponibilizada no formato online e impresso.</p></sec><sec><title>Conclus&#245;es:</title><p>a cartilha educativa foi desenvolvida e validada por especialistas e p&#250;blico-alvo, servindo como uma ferramenta educativa de apoio para o autocuidado e conscientiza&#231;&#227;o da preven&#231;&#227;o do HIV por usu&#225;rios de PrEP.</p></sec></abstract><kwd-group><title>Descritores:</title><kwd>Tecnologia Educacional</kwd><kwd>Preven&#231;&#227;o de Doen&#231;as</kwd><kwd>HIV</kwd><kwd>Profilaxia Pr&#233;-Exposi&#231;&#227;o</kwd><kwd>Enfermagem.</kwd></kwd-group></front-stub><body><sec sec-type="intro"><title>INTRODU&#199;&#195;O</title><p>A infec&#231;&#227;o pelo v&#237;rus da imunodefici&#234;ncia humana (HIV) continua a ser um desafio global de sa&#250;de p&#250;blica, com 85,6 milh&#245;es de pessoas infectadas e 40,4 milh&#245;es de mortes relacionadas &#224; AIDS registradas desde o surgimento da pandemia. Em 2022, 1,3 milh&#227;o de novos casos de HIV foram diagnosticados, resultando em 630 mil mortes por aids<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>.</p><p>Diante da grande preocupa&#231;&#227;o com o controle da transmiss&#227;o do v&#237;rus, durante a c&#250;pula das Na&#231;&#245;es Unidas sobre Objetivos de Desenvolvimento Sustent&#225;vel (ODS), em setembro de 2015, foram estabelecidos 17 objetivos: dentre eles, o objetivo n&#186; 3 &#233; descrito como sa&#250;de e bem-estar, em que engloba metas relacionadas ao tema. Tendo como uma de suas metas a erradica&#231;&#227;o da aids e outras doen&#231;as negligenciadas. A elimina&#231;&#227;o da aids &#233; um objetivo importante para a sa&#250;de p&#250;blica, uma vez que ela ceifou cerca de 630 mil vidas em 2022, segundo estat&#237;sticas da UNAIDS, demonstrando que mesmo com os avan&#231;os alcan&#231;ados pela ci&#234;ncia e pelos esfor&#231;os conjuntos das na&#231;&#245;es, objetivando interromper a cadeia de transmiss&#227;o e diminuir o n&#250;mero de novas infec&#231;&#245;es, ainda ocorrem perdas significativas<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup>.</p><p>A Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) foi implementada no Brasil em 2017 para popula&#231;&#245;es expostas ao HIV, com crit&#233;rios de indica&#231;&#227;o ampliados para toda a popula&#231;&#227;o com mais de 15 anos e peso superior a 35 kg, incluindo casais sorodiferentes e pessoas que usam drogas injet&#225;veis<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>. A PrEP &#233; uma terapia medicamentosa di&#225;ria com antirretrovirais por via oral, segura, com poucos efeitos colaterais e com efic&#225;cia de prote&#231;&#227;o comprovada superior a 90% quando utilizada corretamente<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>. Apesar de sua efic&#225;cia, o conhecimento sobre a PrEP na popula&#231;&#227;o ainda &#233; limitado ou lacunar, o que dificulta sua ado&#231;&#227;o generalizada<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup>.</p><p>Um dos principais desafios atuais enfrentados pelos profissionais de sa&#250;de &#233; a comunica&#231;&#227;o acess&#237;vel de informa&#231;&#245;es sobre a Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP), atendendo &#224;s necessidades e d&#250;vidas tanto dos indiv&#237;duos quanto da comunidade de forma clara e objetiva<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup>. A demanda por educa&#231;&#227;o em sa&#250;de &#233; generalizada, e constantemente discute-se maneiras de fornecer informa&#231;&#245;es e atualiza&#231;&#245;es cient&#237;ficas de forma acess&#237;vel &#224; popula&#231;&#227;o, garantindo que ela possa compreender e utilizar conte&#250;do baseados em evid&#234;ncias confi&#225;veis. Al&#233;m disso, a forma como essas informa&#231;&#245;es s&#227;o disponibilizadas influencia diretamente o processo de aprendizagem e, consequentemente, a sa&#250;de dos indiv&#237;duos<sup>(<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>)</sup>.</p><p>A tecnologia educacional &#233; uma ferramenta crucial na enfermagem para promover estrat&#233;gias de preven&#231;&#227;o em sa&#250;de, incluindo a conscientiza&#231;&#227;o sobre o HIV e m&#233;todos de preven&#231;&#227;o, como a preven&#231;&#227;o combinada. Destaca-se, tamb&#233;m, a import&#226;ncia de indiv&#237;duos com HIV manterem sua carga viral indetect&#225;vel por meio do tratamento, interrompendo assim o ciclo de transmiss&#227;o<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>Considerando a problem&#225;tica da dificuldade de acesso da popula&#231;&#227;o a informa&#231;&#245;es claras e objetivas sobre a PrEP, bem como a necessidade de fortalecer as estrat&#233;gias de preven&#231;&#227;o &#224; aids, conforme delineado no terceiro dos Objetivos de Desenvolvimento Sustent&#225;vel (ODS), &#233; imperativo criar um material de f&#225;cil acesso e entendimento para promover a educa&#231;&#227;o em sa&#250;de. Dessa forma, este estudo teve o objetivo de construir e validar uma cartilha educativa sobre a Profilaxia Pr&#233;-exposi&#231;&#227;o (PrEP) ao HIV.</p></sec><sec><title>OBJETIVOS</title><p>Construir e validar uma cartilha educativa sobre a Profilaxia Pr&#233;-exposi&#231;&#227;o (PrEP) ao HIV.</p></sec><sec sec-type="methods"><title>M&#201;TODOS</title><sec><title>Aspectos &#233;ticos</title><p>O estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa, sendo assegurado o cumprimento &#224;s recomenda&#231;&#245;es da Resolu&#231;&#227;o N&#186; 466/12. Foi conduzido por meio da Plataforma <italic toggle="yes">Research Electronic Data Capture</italic> (REDCAp)<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> com abrang&#234;ncia nacional.</p></sec><sec><title>Desenho, per&#237;odo e local do estudo</title><p>Trata-se de um estudo de valida&#231;&#227;o, quantitativo, desenvolvido em tr&#234;s etapas: constru&#231;&#227;o da cartilha educativa, valida&#231;&#227;o de conte&#250;do com especialistas e valida&#231;&#227;o com o p&#250;blico-alvo, realizada no per&#237;odo de dezembro de 2022 a fevereiro de 2024. Este estudo segue as diretrizes do <italic toggle="yes">Revised Standards for Quality Improvement Reporting Excellence</italic> (SQUIRE 2.0)<sup>(<xref rid="B11" ref-type="bibr">11</xref>-<xref rid="B14" ref-type="bibr">14</xref>)</sup>.</p></sec><sec><title>Constru&#231;&#227;o da cartilha educativa</title><p>A etapa da pr&#233;-produ&#231;&#227;o da cartilha educativa consistiu em uma revis&#227;o de literatura sobre a Profilaxia de Pr&#233;-exposi&#231;&#227;o ao HIV articulada com as recomenda&#231;&#245;es do Protocolo cl&#237;nico e diretrizes terap&#234;uticas para Profilaxia Pr&#233;-exposi&#231;&#227;o (PrEP) (2022) de risco &#224; infec&#231;&#227;o pelo HIV e evid&#234;ncias cient&#237;ficas internacionais atuais, no per&#237;odo de maio a dezembro de 2022<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup>. As publica&#231;&#245;es passaram por leitura cr&#237;tica a fim de se extrair informa&#231;&#245;es &#250;teis para constar na cartilha educativa, sendo definidos os principais t&#243;picos e seus objetivos.</p><p>A produ&#231;&#227;o da cartilha educativa incluiu diagrama&#231;&#227;o e infogr&#225;ficos para facilitar a compreens&#227;o. Um designer especializado em materiais educativos em sa&#250;de foi contratado para este fim. O processo ocorreu de dezembro de 2022 a julho de 2023, seguindo as diretrizes propostas por Moreira (2003) para criar um material educativo eficaz em termos de linguagem, layout e ilustra&#231;&#245;es.</p></sec><sec><title>Amostra e crit&#233;rios de elegibilidade para valida&#231;&#227;o</title><p>Para identifica&#231;&#227;o e sele&#231;&#227;o dos especialistas, fez-se necess&#225;rio o emprego de crit&#233;rios que evidenciam a expertise de conhecimento espec&#237;fico em sa&#250;de sobre o tema do estudo, conforme crit&#233;rios adotados por Fehring (1994)<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>. Para validar a cartilha educativa, foram convidados usu&#225;rios de PrEP em acompanhamento no Centro de Refer&#234;ncia em Especialidades Central de Ribeir&#227;o Preto, entre outubro e dezembro de 2023. Os crit&#233;rios de inclus&#227;o foram: idade acima de 18 anos, estabilidade cl&#237;nica, lucidez e disposi&#231;&#227;o para ler a cartilha. A coleta de dados foi realizada em uma sala do servi&#231;o para garantir o sigilo. Pacientes com incapacidade visual ou cognitiva foram exclu&#237;dos. A sele&#231;&#227;o dos participantes foi feita de forma consecutiva durante o per&#237;odo do estudo. O Consentimento Livre e Esclarecido foi obtido de todos os indiv&#237;duos envolvidos no estudo por meio online.</p></sec><sec><title>Valida&#231;&#227;o dos especialistas</title><p>A etapa de valida&#231;&#227;o foi realizada de forma virtual, refletindo tend&#234;ncias de utilizar a via digital para facilitar a realiza&#231;&#227;o de estudos emp&#237;ricos, servindo como meio para a coleta e divulga&#231;&#227;o de resultados<sup>(<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>)</sup>. O recrutamento empregou o m&#233;todo <italic toggle="yes">Snowball</italic>, como descrito por Fernandes e Carvalho (2003)<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>, adaptado para o uso em redes sociais virtuais como meio de coleta de dados e dissemina&#231;&#227;o de resultados cient&#237;ficos.</p><p>A avalia&#231;&#227;o da cartilha educativa foi conduzida atrav&#233;s de um question&#225;rio autoaplic&#225;vel e virtual, inserido na plataforma REDCap<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> e adaptado do modelo de Valida&#231;&#227;o de Conte&#250;do Diagn&#243;stico de Enfermagem proposto por Fehring (1994)<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>. O question&#225;rio utilizou uma escala do tipo Likert para analisar a cartilha em diferentes aspectos, desde seus objetivos at&#233; sua estrutura, apresenta&#231;&#227;o e relev&#226;ncia. Os participantes puderam fornecer sugest&#245;es e observa&#231;&#245;es sobre os atributos avaliados, incluindo a identifica&#231;&#227;o de erros ou a solicita&#231;&#227;o de acr&#233;scimo de conte&#250;do relevante.</p></sec><sec><title>Valida&#231;&#227;o do p&#250;blico-alvo</title><p>Durante as consultas de acompanhamento da PrEP no servi&#231;o especializado, uma das pesquisadoras do N&#250;cleo de aids e DST (NAIDST) abordava os usu&#225;rios e convidava-os para participar da valida&#231;&#227;o. Ap&#243;s aceita&#231;&#227;o, os participantes recebiam um question&#225;rio semiestruturado sobre dados sociodemogr&#225;ficos, um question&#225;rio para valida&#231;&#227;o elaborado pelos pesquisadores e a cartilha educativa em formato virtual. O question&#225;rio de valida&#231;&#227;o, adaptado de um estudo anterior, continha 20 quest&#245;es agrupadas em organiza&#231;&#227;o, escrita, apar&#234;ncia e motiva&#231;&#227;o. As respostas eram categorizadas como concordo totalmente/concordo (respostas positivas) e discordo/discordo totalmente (respostas negativas).</p></sec><sec><title>An&#225;lise dos resultados e estat&#237;stica</title><p>Para analisar as respostas dos especialistas, utilizou-se o &#205;ndice de Valida&#231;&#227;o de Conte&#250;do (IVC)<sup>(<xref rid="B17" ref-type="bibr">17</xref>)</sup>, que mede a propor&#231;&#227;o de concord&#226;ncia entre os avaliadores. O consenso foi considerado satisfat&#243;rio quando o CVI foi igual ou superior a 80%. O IVC permitiu verificar a concord&#226;ncia dos especialistas em rela&#231;&#227;o &#224; representatividade do conte&#250;do. J&#225; para avaliar as respostas dos usu&#225;rios, utilizou-se o &#205;ndice de Concord&#226;ncia (IC)<sup>(<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B21" ref-type="bibr">21</xref>)</sup>, que calcula o n&#250;mero de concord&#226;ncias dividido pelo total de avalia&#231;&#245;es. Uma concord&#226;ncia superior ou igual a 0,8 foi considerada satisfat&#243;ria. Os dados sociodemogr&#225;ficos foram analisados de forma descritiva, apresentando-se em tabelas, e contribu&#237;ram para poss&#237;veis modifica&#231;&#245;es na cartilha, resultando em sua vers&#227;o final. O estudo recebeu aprova&#231;&#227;o do Comit&#234; de &#201;tica em Pesquisa da Escola de Enfermagem de Ribeir&#227;o Preto, Universidade de S&#227;o Paulo.</p></sec></sec><sec sec-type="results"><title>RESULTADOS</title><sec><title>Constru&#231;&#227;o da cartilha educativa</title><p>A cartilha educativa intitulada <italic toggle="yes">Profilaxia Pr&#233;-Exposi&#231;&#227;o ao V&#237;rus da Imunodefici&#234;ncia Humana: mais uma op&#231;&#227;o de preven&#231;&#227;o ao HIV</italic> (2024) possui 16 p&#225;ginas, dividida em cinco t&#243;picos contando com ilustra&#231;&#245;es e pequenos textos informativos. Para a constru&#231;&#227;o da cartilha educativa foram reunidas as informa&#231;&#245;es b&#225;sicas sobre a PrEP<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup>, a partir do Protocolo Cl&#237;nico e Diretrizes Terap&#234;uticas para Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) de Risco &#224; Infec&#231;&#227;o pelo HIV (2022), e contratado um <italic toggle="yes">designer</italic> profissional considerando a distribui&#231;&#227;o de elementos de forma coesiva, utilizando cores associadas ao tema de sa&#250;de e agrad&#225;veis esteticamente conforme observado na <xref rid="f2" ref-type="fig">Figura 1</xref>.</p><p>
<fig position="float" id="f2" orientation="portrait"><label>Figura 1</label><caption><title>Cartilha educativa: Profilaxia Pr&#233;-Exposi&#231;&#227;o ao V&#237;rus da Imunodefici&#234;ncia Humana</title></caption><graphic position="float" orientation="portrait" xlink:href="0034-7167-reben-78-s1-e20240245-gf02.jpg"/><attrib><italic toggle="yes">Fonte: Cartilha educativa sobre PrEP, 2024.</italic></attrib></fig>
</p><p>O primeiro t&#243;pico da cartilha educativa, intitulado &#8220;Profilaxia Pr&#233;-Exposi&#231;&#227;o ao HIV, como funciona?&#8221;, descreve como os medicamentos funcionam e a indica&#231;&#227;o da PrEP. O segundo t&#243;pico, &#8220;Efic&#225;cia e Benef&#237;cio&#8221;, aborda quest&#245;es como quando a PrEP come&#231;a a fazer efeito, o acompanhamento necess&#225;rio, benef&#237;cios e efeitos colaterais. O terceiro t&#243;pico, &#8220;Quero utilizar&#8221;, responde quem pode utilizar a PrEP, como iniciar e continuar seu uso, com base no protocolo brasileiro. O conte&#250;do foi adaptado para ser acess&#237;vel, livre de termos t&#233;cnicos complexos e l&#250;dico, visando alcan&#231;ar e ser compreendido pela popula&#231;&#227;o em diferentes contextos. O quarto t&#243;pico, &#8220;Estrat&#233;gias para n&#227;o esquecer de tomar&#8221;, oferece seis orienta&#231;&#245;es simples para melhorar a ades&#227;o &#224; PrEP, como anota&#231;&#245;es e o uso de despertadores. Por fim, o quinto t&#243;pico, &#8220;Onde buscar mais informa&#231;&#245;es&#8221;, lista sites oficiais e endere&#231;os eletr&#244;nicos para obter informa&#231;&#245;es adicionais sobre a PrEP<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>Os infogr&#225;ficos foram inseridos ao longo do texto para facilitar a leitura e foram elaborados elementos que buscam refor&#231;ar a mensagem escrita. A cor predominante utilizada foi a cor azul, que Fernandes e Ara&#250;jo (2018)<sup>(<xref rid="B23" ref-type="bibr">23</xref>)</sup> descrevem como uma cor capaz de trazer a sensa&#231;&#227;o de calma e relaxamento e afastar a sensa&#231;&#227;o de pressa e agita&#231;&#227;o que o indiv&#237;duo carrega todos os dias.</p></sec><sec><title>Valida&#231;&#227;o da cartilha educativa pelos especialistas</title><p>A etapa de valida&#231;&#227;o da cartilha educativa contou com a participa&#231;&#227;o de 32 especialistas. Estes eram predominantemente graduados em Enfermagem 29 (93,5%), do sexo feminino 18 (56,3%) de regi&#245;es distintas do pa&#237;s. A m&#233;dia do tempo de atua&#231;&#227;o na &#225;rea foi de 8,4 anos (DP=9,0). Com rela&#231;&#227;o &#224; &#225;rea de atua&#231;&#227;o, 11 (34,4%) dos especialistas pertencem &#224; assist&#234;ncia; 10 (31,3%) &#224; doc&#234;ncia, e 9 (28,1%) &#224; pesquisa. Dos 32 participantes, 15 (46,9%) atuam na &#225;rea da infectologia, 8 (26,7%) possuem doutorado como maior n&#237;vel de forma&#231;&#227;o; 16 (53,3%) possuem conhecimento em HIV/aids adquirido no local de trabalho; e 6 (20,0%) atrav&#233;s de publica&#231;&#245;es na &#225;rea. Entre os participantes, 28 (87,5%) atuam e realizam orienta&#231;&#245;es diariamente aos usu&#225;rios sobre a PrEP.</p><p>O question&#225;rio de valida&#231;&#227;o da cartilha educativa compreende 55 atributos, cada um com afirma&#231;&#245;es avaliadas pelos especialistas, variando de &#8220;Concordo totalmente&#8221; a &#8220;Discordo totalmente&#8221;. A valida&#231;&#227;o de um atributo requer que a soma das respostas &#8220;Concordo totalmente&#8221; e &#8220;Concordo&#8221; seja superior a 80% do total das respostas. Os atributos s&#227;o distribu&#237;dos em tr&#234;s dom&#237;nios: &#8220;Avalia&#231;&#227;o geral&#8221;, &#8220;Conte&#250;do&#8221; e &#8220;Qualidade est&#233;tica e visual&#8221;. O dom&#237;nio de &#8220;Avalia&#231;&#227;o geral&#8221; inclui 10 atributos, listados na <xref rid="t5" ref-type="table">Tabela 1</xref>, juntamente com seus respectivos I-CVIs.</p><table-wrap position="float" id="t5" orientation="portrait"><label>Tabela 1</label><caption><title>Avalia&#231;&#227;o geral da cartilha educativa pelos especialistas na &#225;rea da sa&#250;de (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brasil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Atributos avaliados</th><th align="center" rowspan="2" colspan="1">CT</th><th align="center" rowspan="2" colspan="1">C</th><th align="center" rowspan="2" colspan="1">NS</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">DT</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" rowspan="1" colspan="1">Avalia&#231;&#227;o geral</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o do uso da PrEP</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o da efic&#225;cia da PrEP</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o dos benef&#237;cios da PrEP</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o dos poss&#237;veis efeitos colaterais da PrEP</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,94</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o dos crit&#233;rios de elegibilidade para uso da PrEP</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o sobre a ades&#227;o &#224; PrEP</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o de estrat&#233;gias facilitadoras para o acompanhamento da PrEP</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha est&#225; descrita de forma a permitir a compreens&#227;o de estrat&#233;gias facilitadoras para o acompanhamento da PrEP</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" rowspan="1" colspan="1">&#201; coerente com as necessidades das pessoas em uso da PrEP</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" rowspan="1" colspan="1">&#201; coerente com as necessidades das pessoas em uso da PrEP</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,97</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>*</label><p>
<italic toggle="yes">N&#186; de especialistas que escolheram a op&#231;&#227;o: CT - Concordo totalmente; C - Concordo; NS - N&#227;o sei; D - Discordo; DT - Discordo totalmente. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>O dom&#237;nio de conte&#250;do e linguagem escrita (<xref rid="t6" ref-type="table">Tabela 2</xref>), composto por 22 atributos, alcan&#231;ou um S-CVI/Ave de 0,96, variando de 0,88 a 1,00. Ap&#243;s a an&#225;lise das sugest&#245;es dos especialistas, identificou-se a necessidade de refor&#231;ar as poss&#237;veis contraindica&#231;&#245;es ao uso concomitante da PrEP, enfatizar que ela n&#227;o previne outras IST e aprimorar a exposi&#231;&#227;o sobre o uso de preservativos internos e externos.</p><table-wrap position="float" id="t6" orientation="portrait"><label>Tabela 2</label><caption><title>Avalia&#231;&#227;o de conte&#250;do e linguagem escrita da cartilha educativa pelos especialistas na &#225;rea da sa&#250;de (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brasil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Atributos avaliados</th><th align="center" rowspan="2" colspan="1">CT</th><th align="center" rowspan="2" colspan="1">C</th><th align="center" rowspan="2" colspan="1">NS</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">DT</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Conte&#250;do</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre o uso da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre a efic&#225;cia da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre os benef&#237;cios da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre os poss&#237;veis efeitos colaterais da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre os crit&#233;rios de elegibilidade da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre a ades&#227;o ao tratamento da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para orienta&#231;&#227;o sobre estrat&#233;gias facilitadoras para o acompanhamento da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A sequ&#234;ncia do conte&#250;do da cartilha est&#225; adequada</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o do tema</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Os conte&#250;dos abordados est&#227;o de acordo com o conhecimento atual</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o do uso da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o da efic&#225;cia da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o dos benef&#237;cios da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o dos poss&#237;veis efeitos colaterais da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do est&#225; adequado ao p&#250;blico-alvo (pessoas adultas em uso da PrEP)</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o sobre a ades&#227;o ao tratamento da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O conte&#250;do permite a compreens&#227;o de estrat&#233;gias facilitadoras para o acompanhamento da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">As orienta&#231;&#245;es apresentadas s&#227;o pertinentes</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">As orienta&#231;&#245;es apresentadas foram abordadas corretamente</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">As informa&#231;&#245;es s&#227;o apropriadas ao p&#250;blico-alvo</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">As informa&#231;&#245;es s&#227;o apresentadas em um contexto<break/>pertinente ao p&#250;blico-alvo</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha disp&#245;e de todas as informa&#231;&#245;es necess&#225;rias para o uso da PrEP</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0,94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0,96</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>*</label><p>
<italic toggle="yes">N&#186; de especialistas que escolheram a op&#231;&#227;o: CT - Concordo totalmente; C - Concordo; NS - N&#227;o sei; D - Discordo; DT - Discordo totalmente. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>O &#250;ltimo dom&#237;nio avaliado pelos especialistas foi a qualidade est&#233;tica e visual da cartilha educativa, composto por 8 atributos. O objetivo era verificar se o material &#233; atrativo e desperta interesse por meio de suas cores e imagens. O dom&#237;nio obteve um IVC total de 0,91, atendendo ao valor m&#237;nimo necess&#225;rio para aprova&#231;&#227;o em todos os atributos, conforme demonstrado na <xref rid="t7" ref-type="table">Tabela 3</xref>. No entanto, os especialistas sugeriram melhorias, como aumentar o tamanho da letra, incluir mais diversidade de personagens e tornar a cartilha mais colorida e atrativa, especialmente para adolescentes.</p><table-wrap position="float" id="t7" orientation="portrait"><label>Tabela 3</label><caption><title>Avalia&#231;&#227;o da qualidade est&#233;tica e visual da cartilha educativa pelos especialistas na &#225;rea da sa&#250;de (N=32), Ribeir&#227;o Preto, S&#227;o Paulo, Brasil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Atributos avaliados</th><th align="center" rowspan="2" colspan="1">CT</th><th align="center" rowspan="2" colspan="1">C</th><th align="center" rowspan="2" colspan="1">NS</th><th align="center" rowspan="2" colspan="1">D</th><th align="center" rowspan="2" colspan="1">DT</th><th align="center" rowspan="2" colspan="1">I-CVI</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Qualidade est&#233;tica e visual</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">O aspecto visual da cartilha &#233; interessante</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O aspecto visual da cartilha &#233; motivador para a leitura</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0,94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A cartilha apresenta uma est&#233;tica/layout satisfat&#243;rio</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O formato e tamanho das letras est&#227;o satisfat&#243;rios</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Os infogr&#225;ficos elaborados ret&#234;m as orienta&#231;&#245;es por escrito</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A qualidade dos infogr&#225;ficos &#233; satisfat&#243;ria</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,97</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">As cores utilizadas n&#227;o atrapalham a leitura</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A diagrama&#231;&#227;o favorece o entendimento da mensagem</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">0,94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S-CVI/Ave</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0,91</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><label>*</label><p>
<italic toggle="yes">N&#186; de especialistas que escolheram a op&#231;&#227;o: CT - Concordo totalmente; C - Concordo; NS - N&#227;o sei; D - Discordo; DT - Discordo totalmente. I-CVI = Item-Level Content Validity Index. S-CVI/Ave = Scale-level Content Validity Index, Average calculation method.</italic>
</p></fn></table-wrap-foot></table-wrap><p>As sugest&#245;es dos especialistas foram acatadas e uma vers&#227;o final da cartilha educativa foi elaborada levando em considera&#231;&#227;o as modifica&#231;&#245;es sugeridas por especialistas como relevantes para compor a cartilha educativa.</p><p>O &#205;ndice de Validade de Conte&#250;do (S-CVI/UA) global da valida&#231;&#227;o com os especialistas se deu pela m&#233;dia de IVC total, ou seja, a somat&#243;ria dos S-CVI/Ave de cada dom&#237;nio dividido pelo n&#250;mero de dom&#237;nios (4), cujo resultado foi 0,94, validando, dessa forma, a cartilha educativa mediante todos os &#205;ndice de Validade de Conte&#250;do (por atributos, dom&#237;nio e global) sendo alcan&#231;ado um valor igual ou maior a 0,80.</p></sec><sec><title>Valida&#231;&#227;o da cartilha educativa pelo p&#250;blico-alvo</title><p>A valida&#231;&#227;o junto ao p&#250;blico-alvo contou com 13 usu&#225;rios de PrEP, com idade m&#233;dia de 36,7 anos, todos do sexo masculino, cisg&#234;nero e homens que fazem sexo com homens (HSH). A maioria dos participantes (84,6%) era solteira, e a maioria possu&#237;a gradua&#231;&#227;o completa (38,5%) e v&#237;nculo empregat&#237;cio (46,2%). Todos os participantes (100%) eram usu&#225;rios atuais da PrEP, recebiam orienta&#231;&#245;es de acompanhamento e pretendiam continuar utilizando. Os resultados sobre a organiza&#231;&#227;o do material, estilo da escrita, apar&#234;ncia e motiva&#231;&#227;o est&#227;o apresentados na <xref rid="t8" ref-type="table">Tabela 4</xref>.</p><table-wrap position="float" id="t8" orientation="portrait"><label>Tabela 4</label><caption><title>Avalia&#231;&#227;o da organiza&#231;&#227;o, escrita, apar&#234;ncia e motiva&#231;&#227;o da cartilha educativa pelo p&#250;blico-alvo (n=13), Ribeir&#227;o Preto, S&#227;o Paulo, Brasil, 2024</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Atributos avaliados</th><th align="center" rowspan="2" colspan="1">CT/C</th><th align="center" rowspan="2" colspan="1">D/DT</th><th align="center" rowspan="2" colspan="1">IVC</th></tr><tr><th align="left" rowspan="1" colspan="1">Organiza&#231;&#227;o</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">As informa&#231;&#245;es disponibilizadas na cartilha s&#227;o f&#225;ceis de entender.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">As informa&#231;&#245;es disponibilizadas na cartilha s&#227;o importantes</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">As informa&#231;&#245;es da cartilha ajudam a decidir se quero ou n&#227;o utilizar a PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">Escrita e apar&#234;ncia</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Eu gostei como o conte&#250;do da cartilha foi apresentado.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">As imagens ajudam a entender o conte&#250;do da cartilha.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">As cores utilizadas na cartilha s&#227;o atrativas.</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0,85</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha possibilita compreender o que &#233; a PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha possibilita compreender os benef&#237;cios de usar a PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha me ajudou a compreender a import&#226;ncia do acompanhamento profissional durante o uso da PrEP.</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha possibilita a compreens&#227;o de poss&#237;veis efeitos colaterais da PrEP</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0,85</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha ajuda a compreender alguns cuidados que devem ser feitos durante o uso da PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha permite que eu saiba onde buscar a PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha permite compreender quem pode utilizar a PrEP</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">Motiva&#231;&#227;o</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha pode ser um facilitador da busca pela PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">A cartilha me fez perceber que eu me encaixo nos crit&#233;rios de indica&#231;&#227;o para a PrEP.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">As informa&#231;&#245;es desta cartilha me causaram interesse em buscar/ iniciar a PrEP</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0,92</td></tr><tr><td align="left" rowspan="1" colspan="1">As informa&#231;&#245;es desta cartilha que podem ajudar a melhorar a ades&#227;o a PrEP.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">Eu conhe&#231;o algu&#233;m que se beneficiaria lendo essa cartilha</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr><tr><td align="left" rowspan="1" colspan="1">Essa cartilha pode ser uma ferramenta complementar em atividades de educa&#231;&#227;o sexual para maiores de 16 anos.</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1,00</td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><label>*</label><p>
<italic toggle="yes">N&#186; de especialistas que escolheram a op&#231;&#227;o: CT - Concordo totalmente; C - Concordo; D - Discordo; DT - Discordo totalmente. I-CVI = Item-Level Content Validity Index, 2024.</italic>
</p></fn></table-wrap-foot></table-wrap><p>Duas respostas negativas foram destacadas nas avalia&#231;&#245;es do p&#250;blico-alvo, resultando em um IC de 0,85 na categoria escrita. Os participantes foram convidados a fornecer sugest&#245;es e coment&#225;rios, que abordaram a necessidade de detalhes sobre onde buscar a PrEP no SUS e no sistema privado. Observa&#231;&#245;es positivas tamb&#233;m foram registradas, elogiando o f&#225;cil entendimento e a pertin&#234;ncia da cartilha para quem deseja ou utiliza a PrEP.</p></sec></sec><sec sec-type="discussion"><title>DISCUSS&#195;O</title><p>Este estudo descreve a constru&#231;&#227;o e valida&#231;&#227;o de uma cartilha educativa destinada a usu&#225;rios da Profilaxia Pr&#233;-Exposi&#231;&#227;o (PrEP) ao HIV, com o objetivo de apoiar suas estrat&#233;gias de preven&#231;&#227;o e autocuidado. Desenvolvida com base na literatura e validada por profissionais de sa&#250;de e usu&#225;rios de PrEP, essa ferramenta educativa visa promover o uso consciente da PrEP e ampliar seu alcance. O uso de tecnologias educativas como essa cartilha &#233; fundamental para aumentar o conhecimento, promover a autonomia e facilitar o autocuidado, especialmente em um contexto onde as orienta&#231;&#245;es verbais predominam, garantindo que as necessidades educacionais dos usu&#225;rios de PrEP sejam atendidas de maneira individualizada e centrada na pessoa.</p><p>No contexto atual, a luta contra a aids continua h&#225; mais de quatro d&#233;cadas, sendo considerada ainda uma doen&#231;a repleta de estigmas sociais, especialmente relacionados &#224;s minorias sexuais, como as LGBTQIA+<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup>. Ao longo desse tempo, houve grandes avan&#231;os na &#225;rea da sa&#250;de e na &#225;rea tecnol&#243;gica, facilitando o acesso a novas informa&#231;&#245;es. De fato, o maior acesso a informa&#231;&#245;es pela popula&#231;&#227;o impacta diretamente em quest&#245;es de sa&#250;de p&#250;blica, uma vez que a alfabetiza&#231;&#227;o em sa&#250;de proporciona ao indiv&#237;duo capacidade de exercer autonomia sobre seus processos de sa&#250;de, e fortalecer a tomada de decis&#245;es de forma mais consciente e informada<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>O controle da transmiss&#227;o do HIV ainda &#233; um grande desafio global e mediante isso, diversas metas foram estabelecidas a fim de tentar atingi-lo. Um exemplo disso, &#233; uma das metas dos ODS, especificamente a meta de sa&#250;de e bem-estar, que visa a elimina&#231;&#227;o da aids at&#233; o ano de 2030<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup>. Dessa forma, um modo de auxiliar a atingir a erradica&#231;&#227;o da aids &#233; atrav&#233;s da alfabetiza&#231;&#227;o em sa&#250;de da popula&#231;&#227;o quanto aos m&#233;todos de preven&#231;&#227;o. Para que tal processo ocorra, materiais did&#225;ticos que facilitem a compreens&#227;o das informa&#231;&#245;es se fazem necess&#225;rios<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup>.</p><p>As tecnologias educativas t&#234;m desempenhado um papel fundamental na educa&#231;&#227;o em sa&#250;de, especialmente ao direcionar estrat&#233;gias para a conscientiza&#231;&#227;o dos assuntos que tratam de determinados t&#243;picos; atrav&#233;s da exposi&#231;&#227;o l&#250;dica e interativa para o p&#250;blico o qual pretende atingir; pode ser redigida com f&#225;cil entendimento em mente, utiliza&#231;&#227;o de linguagem simplificada e inser&#231;&#227;o de informa&#231;&#245;es relevantes<sup>(<xref rid="B24" ref-type="bibr">24</xref>)</sup>. No caso da cartilha desenvolvida no correr deste estudo, ela exerce a fun&#231;&#227;o de conscientizar o p&#250;blico-alvo sobre as lutas de erradica&#231;&#227;o da aids, preven&#231;&#227;o e maior seguran&#231;a, com a garantia de evid&#234;ncias fidedignas, atualizadas e escritas de maneira acess&#237;vel, tanto em termos de vocabul&#225;rio como de f&#225;cil interpreta&#231;&#227;o.</p><p>Uma cartilha educativa, seja ela no formato impresso ou online, auxilia na dispers&#227;o do conhecimento com amplo alcance de indiv&#237;duos em ambas as modalidades. A cartilha educativa que tenha como objetivo a alfabetiza&#231;&#227;o em sa&#250;de - contendo textos de f&#225;cil compreens&#227;o e imagens autoexplicativas que facilitem o entendimento do material, especialmente - tem o potencial de alcan&#231;ar popula&#231;&#245;es vulner&#225;veis, uma vez que n&#227;o necessitam de suporte adjacente, como uma conex&#227;o com a internet e aparelhos eletr&#244;nicos para leitura. Dessa forma, a cartilha vem sendo uma grande ferramenta para profissionais da sa&#250;de, no &#226;mbito de enfrentamento e implementa&#231;&#227;o de estrat&#233;gias de preven&#231;&#227;o em sa&#250;de<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup>.</p><p>A cartilha educativa abordou os principais t&#243;picos identificados nas evid&#234;ncias cient&#237;ficas relacionadas &#224; PrEP, como o funcionamento, indica&#231;&#227;o, efic&#225;cia, benef&#237;cios e efeitos colaterais, obtendo um &#205;ndice de Validade de Conte&#250;do (S-CVI/UA) Global de 0,94, acima da meta considerada para a aprova&#231;&#227;o, sendo ela um &#237;ndice superior a 0,80. Dessa forma, considera-se v&#225;lida por especialistas da &#225;rea da sa&#250;de e p&#250;blico-alvo para uso futuro como tecnologia educativa com a popula&#231;&#227;o, uma vez que, a cartilha foi desenvolvida a fim de disponibilizar informa&#231;&#245;es atualizadas sobre a PrEP de maneira acess&#237;vel.</p><p>A valida&#231;&#227;o com o p&#250;blico-alvo revelou uma avalia&#231;&#227;o geral positiva da cartilha em rela&#231;&#227;o &#224; escrita, apar&#234;ncia e motiva&#231;&#227;o. Apesar de algumas opini&#245;es sobre as cores, a maioria dos usu&#225;rios a considerou &#250;til para promover a educa&#231;&#227;o em sa&#250;de al&#233;m do servi&#231;o especializado. As cores foram ajustadas para melhor atender ao perfil dos usu&#225;rios, assim como a escrita dos efeitos colaterais foi simplificada. Essa valida&#231;&#227;o &#233; crucial para identificar lacunas de compreens&#227;o e garantir que o material educativo seja acess&#237;vel e relevante para diferentes n&#237;veis de letramento em sa&#250;de. Uma apresenta&#231;&#227;o organizada e atrativa do conte&#250;do &#233; fundamental para uma leitura eficaz, alinhada com os interesses e necessidades dos leitores.</p><p>Uma cartilha educativa bem desenvolvida &#233; um recurso valioso em estrat&#233;gias de educa&#231;&#227;o em sa&#250;de, facilitando a compreens&#227;o, sendo acess&#237;vel e refor&#231;ando as orienta&#231;&#245;es fornecidas verbalmente pela equipe de sa&#250;de. O formato impresso oferece a vantagem de poder ser consultado posteriormente, servindo como apoio para consultas e leituras ao longo do tempo e favorecer a comunica&#231;&#227;o com a equipe de sa&#250;de. Ressalta-se ainda que a cartilha n&#227;o substitui o profissional de sa&#250;de, nas a&#231;&#245;es de educa&#231;&#227;o em sa&#250;de, no entanto, pode facilitar a comunica&#231;&#227;o e estimular o autocuidado<sup>(<xref rid="B24" ref-type="bibr">24</xref>)</sup>.</p><sec><title>Limita&#231;&#245;es do estudo</title><p>A valida&#231;&#227;o da cartilha foi feita com adultos jovens com alto n&#237;vel educacional j&#225; vinculados a um servi&#231;o especializado, excluindo grupos com baixa escolaridade. Apesar disso, todas as etapas foram cumpridas. A popula&#231;&#227;o validada reflete usu&#225;rios reais da PrEP no pa&#237;s. Sugere-se criar outras tecnologias educacionais, como jogos e v&#237;deos, para alcan&#231;ar diferentes grupos populacionais.</p></sec><sec><title>Contribui&#231;&#245;es para a &#225;rea</title><p>A constru&#231;&#227;o e valida&#231;&#227;o de uma cartilha in&#233;dita para usu&#225;rios da PrEP representa uma importante tecnologia educativa, de baixo custo e de f&#225;cil implementa&#231;&#227;o nos servi&#231;os de sa&#250;de. Pode alcan&#231;ar uma ampla audi&#234;ncia e ser utilizada em interven&#231;&#245;es educativas como estrat&#233;gia de ensino-aprendizagem pela equipe de enfermagem e outros profissionais de sa&#250;de. Este estudo aborda os principais t&#243;picos a serem inclu&#237;dos nas orienta&#231;&#245;es para o uso da PrEP, destacando a import&#226;ncia do enfermeiro no processo de educa&#231;&#227;o para a sa&#250;de.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUS&#213;ES</title><p>A cartilha educativa sobre a PrEP foi elaborada em cinco t&#243;picos e validada por profissionais experientes e usu&#225;rios. Sua vers&#227;o final impressa pode ser utilizada como um recurso complementar &#224;s orienta&#231;&#245;es fornecidas por enfermeiros e m&#233;dicos durante o acompanhamento especializado, auxiliando assim na garantia do acesso universal a servi&#231;os de sa&#250;de de qualidade. Tal acesso &#233; crucial para o alcance do terceiro dos Objetivos de Desenvolvimento Sustent&#225;vel da ONU. Al&#233;m disso, a cartilha visa fortalecer a alfabetiza&#231;&#227;o em sa&#250;de sobre a PrEP, um m&#233;todo de preven&#231;&#227;o do HIV gratuito disponibilizado pelo SUS. Isso capacita os indiv&#237;duos a tomarem decis&#245;es informadas sobre sua sa&#250;de, promovendo, assim, seu empoderamento e autonomia.</p></sec></body><back><sec sec-type="data-availability" specific-use="uninformed"><label>DISPONIBILIDADE DE DADOS E MATERIAL</label><p>N&#227;o se aplica.</p></sec></back></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>